Hot Pursuit     16-Apr-24
Caplin Point rises on USFDA nod for eye drops
Caplin Point Laboratories added 1.67% to Rs 1,318.75 after its subsidiary, Caplin Steriles received final approval from the US drug regulator for its abbreviated new drug application (ANDA) Ofloxacin Ophthalmic Solution.
The approved ANDA is a generic therapeutic equivalent version of reference listed drug (RLD), Ocuflox Ophthalmic Solution of Allergan Inc.

Ofloxacin Ophthalmic Solution (eye drops) is indicated for treatment of eye infections caused during the conditions of conjunctivitis and corneal ulcers.

According to IQVIA (IMS Health), Ofloxacin Ophthalmic Solution had US sales of approximately $52 million for the 12- month period ending December 2023.

Caplin Point Laboratories is a fast-growing pharmaceutical company with a unique business model catering predominantly to emerging markets of Latin America and Africa. The company has manufacturing facilities that cater to a complete range of finished dosage forms.

The company‘s consolidated net profit jumped 30.1% to Rs 119.82 crore on 17% increase in revenue from operations to Rs 435.50 crore in Q3 FY24 over Q3 FY23.

Previous News
  Caplin Point Laboratories fixes record date for interim dividend
 ( Market Beat - Reports 16-May-24   18:48 )
  Board of Caplin Point Laboratories recommends final dividend
 ( Corporate News - 06-Aug-22   09:58 )
  Anand Rathi Wealth Ltd leads losers in 'A' group
 ( Hot Pursuit - 02-Apr-24   15:00 )
  Caplin Steriles receives USFDA approval for Carboprost Tromethamine Injection
 ( Corporate News - 14-Feb-23   11:49 )
  Caplin Point Laboratories consolidated net profit rises 16.27% in the December 2021 quarter
 ( Results - Announcements 03-Feb-22   14:02 )
  Caplin Point Laboratories to hold board meeting
 ( Corporate News - 29-Oct-19   12:22 )
  Caplin receives USFDA approval for Neostigmine Methylsulfate Injection
 ( Corporate News - 22-Apr-21   09:05 )
  Caplin Point Laboratories consolidated net profit rises 127.49% in the June 2017 quarter
 ( Results - Announcements 07-Aug-17   17:32 )
  Caplin Point Laboratories standalone net profit declines 9.56% in the September 2018 quarter
 ( Results - Announcements 03-Nov-18   08:18 )
  Volumes soar at Spandana Sphoorty Financial Ltd counter
 ( Hot Pursuit - 05-Feb-20   14:30 )
  Caplin Point Laboratories standalone net profit rises 70.99% in the June 2017 quarter
 ( Results - Announcements 07-Aug-17   17:32 )
Other Stories
  Tata Motors JLR wholesale rises 5% YoY in Q1
  06-Jul-24   13:01
  Marico's domestic biz sees modest volume growth in Q1
  06-Jul-24   12:25
  Titan revenue rises 9% YoY, adds 61 stores in Q1
  06-Jul-24   11:09
  Dabur India expects mid to high digit revenue growth in Q1
  06-Jul-24   10:40
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
Back Top